OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular disease and diabetes, announces the departure of Christina Wood as Executive Sales & Marketing Director by mutual agreement. Dr Fred Narbel, Managing Director of OptiBiotix’s prebiotic division containing its SweetBiotix, OptiBiotic and microbiome modulating technology platforms will take over Christina’s responsibilities for SlimBiome and GoFigure.
OptiBiotix will continue to evolve the executive and non-executive team in-line with the changing needs of the business with the aim of delivering profitable divisions across all areas of the Company.
Stephen O’Hara, CEO of OptiBiotix, commented: “On behalf of the Board, I would like to thank Christina for her professionalism and hard work with OptiBiotix and wish her all the best in the future”.
optibiotix-h